Combinatorial drug therapy for cancer in the post-genomic era

Al-Lazikani, Bissan, Banerji, Udai, Workman, Paul·2012·Nature Biotechnology

DOI 10.1038/nbt.2284

Cited by (999)

Items 401–500 of 999

Combi-seq for multiplexed transcriptome-based profiling of drug combinations using deterministic barcoding in single-cell droplets
Lukas Mathur, Bence Szalai, N. H. Du, Ramesh Utharala, Martine Ballinger, Jonathan J. M. Landry, Michaël Ryckelynck, Vladimı́r Beneš, Julio Sáez-Rodríguez, Christoph A. Merten · 2022 · Nature Communications
Targeting molecular networks for drug research
José Pinto, Rui S. R. Machado, Joana M. Xavier, Matthias E. Futschik · 2014 · Frontiers in Genetics
Synergistic increase in efficacy of a combination of 2-deoxy-d-glucose and cisplatin in normoxia and hypoxia: switch from autophagy to apoptosis
Akansha Jalota, Mukesh Kumar, Bhudev Chandra Das, Ajay K. Yadav, Kunzang Chosdol, Subrata Sinha · 2016 · Tumor Biology
Aptamer-Functionalized Upconverting Nanoformulations for Light-Switching Cancer-Specific Recognition and In Situ Photodynamic–Chemo Sequential Theranostics
Xudong Jin, Qin Zeng, Judun Zheng, Da Xing, Tao Zhang · 2020 · ACS Applied Materials & Interfaces
Informatics Approaches for Predicting, Understanding, and Testing Cancer Drug Combinations
Jing Ping Tang · 2017 · Methods in molecular biology
Identification and Therapeutic Intervention of Coactivated Anaplastic Lymphoma Kinase, Fibroblast Growth Factor Receptor 2, and Ephrin Type‐A Receptor 5 Kinases in Hepatocellular Carcinoma
Xin Wang, Minmin Zhang, Fangfang Ping, Hong‐Chun Liu, Jingya Sun, Yueqin Wang, Aijun Shen, Jian Ding, Meiyu Geng · 2018 · Hepatology
Fundamentals of Stimuli-responsive Drug and Gene Delivery Systems
Vladimir P. Torchilin · 2018 · Royal Society of Chemistry eBooks
Differentiating between cancer and normal tissue samples using multi-hit combinations of genetic mutations
Sajal Dash, Nicholas Allen Kinney, Robin T. Varghese, Harold R. Garner, Wu-chun Feng, Ramu Anandakrishnan · 2019 · Scientific Reports
Selective Cytotoxicity of a Novel Trp‐Rich Peptide against Lung Tumor Spheroids Encapsulated inside a 3D Microfluidic Device
Nandini Dhiman, Nadin Shagaghi, Mrinal R. Bhave, Hüseyin Sümer, Peter Kingshott, Subha Narayan Rath · 2020 · Advanced Biosystems
Dissecting the Tumor–Immune Landscape in Chimeric Antigen Receptor T-cell Therapy: Key Challenges and Opportunities for a Systems Immunology Approach
Gregory M. Chen, Andrew Azzam, Yangyang Ding, David Maxwell Barrett, Stephan A. Grupp, Kai Tan · 2020 · Clinical Cancer Research
Drug2ways: Reasoning over causal paths in biological networks for drug discovery
Daniel Rivas-Barragan, Sarah Mubeen, Francesc Guim, Martin Hofmann‐Apitius, Daniel Domingo‐Fernándéz · 2020 · PLoS Computational Biology
Modeling drug combination effects via latent tensor reconstruction
Tianduanyi Wang, Sándor Szedmák, Haishan Wang, Tero A. Aittokallio, Tapio Pahikkala, Anna Cichońska, Juho Rousu · 2021 · Bioinformatics
Low Dose of Doxorubicin Potentiates the Effect of Temozolomide in Glioblastoma Cells
Emilly S. Villodre, Franciele Cristina Kipper, Andrew Oliveira Silva, Guido Lenz, Patrícia Luciana da Costa Lopez · 2017 · Molecular Neurobiology
Attenuating the emergence of anti-fungal drug resistance by harnessing synthetic lethal interactions in a model organism
Usher, Jane, Haynes, Ken · 2019 · PLOS Genetics
Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor Models
Mao, Binchen, Guo, Sheng · 2023 · Cancer Research Communications
Durability of Kinase-Directed Therapies—A Network Perspective on Response and Resistance
Brion William Murray, Nichol L. G. Miller · 2015 · Molecular Cancer Therapeutics
Reductive metabolism of oxymatrine is catalyzed by microsomal CYP3A4
Zhongqiu Liu, Wenqin Liu, Jian Shi, Lijun Zhu, Lingna Dong, Feifei Luo, Min Zhao, Ying Wang, Ming Hu, Linlin Lu · 2015 · Drug Design Development and Therapy
Tetra-O-Methyl Nordihydroguaiaretic Acid Broadly Suppresses Cancer Metabolism and Synergistically Induces Strong Anticancer Activity in Combination with Etoposide, Rapamycin and UCN-01
Kotohiko Kimura, Ru Chih C. Huang · 2016 · PLoS ONE
Stress – (self) eating: Epigenetic regulation of autophagy in response to psychological stress
Deepika Puri, Deepa Subramanyam · 2019 · FEBS Journal
Drug Nanorod-Mediated Intracellular Delivery of microRNA-101 for Self-sensitization via Autophagy Inhibition
Xiaofei Xin, Xiaoqing Du, Qingqing Xiao, Helena S. Azevedo, Wei He, Lifang Yin · 2019 · Nano-Micro Letters
Simultaneous Optimization of Drug Combination Dose‐Ratio Sequence with Innovative Design and Active Learning
Aiting Wang, Hongquan Xu, Xianting Ding · 2020 · Advanced Therapeutics
Fatty Acid Oxidation Is an Adaptive Survival Pathway Induced in Prostate Tumors by HSP90 Inhibition
Zeyad D. Nassar, Chui Yan Mah, Margaret M. Centenera, Swati Irani, Martin C. Sadowski, Julia S. Scott, Elizabeth V. Nguyen, Shilpa R. Nagarajan, Max V. Moldovan, David John Lynn et al. · 2020 · Molecular Cancer Research
Predicting Metabolism‐Related Drug–Drug Interactions Using a Microphysiological Multitissue System
Christian Lohasz, Flavio Bonanini, Lisa Hoelting, Kasper Renggli, Olivier Frey, Andreas R. Hierlemann · 2020 · Advanced Biosystems
Magnesium in Combinatorial With Valproic Acid Suppressed the Proliferation and Migration of Human Bladder Cancer Cells
Tianye Li, Yang Yu, Hang Shi, Yuhua Cao, Xiangfu Liu, Zhenzhen Hao, Yuping Ren, Gaowu W. Qin, Yongye Huang, Bing Wang · 2020 · Frontiers in Oncology
ROS-Mediated Necrosis by Glycolipid Biosurfactants on Lung, Breast, and Skin Melanoma Cells
Farazul Haque, Mohd Shariq Khan, Naif Alqurashi · 2021 · Frontiers in Oncology
Paclitaxel-Loaded Biotinylated Fe2+-Doped Carbon Dot: Combination Therapy in Cancer Treatment
Monalisa Chowdhury, Prasanta Kumar Das · 2021 · ACS Applied Bio Materials
Anti-Cancer Drug Screening with Microfluidic Technology
Mojdeh Monjezi, Milad Rismanian, Hamidreza Jamaati, Navid Kashaninejad · 2021 · Applied Sciences
High‐Throughput Cellular Heterogeneity Analysis in Cell Migration at the Single‐Cell Level
Mengli Zhou, Yushu Ma, Chun‐Cheng Chiang, Edwin C. Rock, Kathryn E. Luker, Gary D. Luker, Yu‐Chih Chen · 2022 · Small
MM-GANN-DDI: Multimodal Graph-Agnostic Neural Networks for Predicting Drug–Drug Interaction Events
Junning Feng, Yong Qi Liang, Tianwei Yu · 2023 · Computers in Biology and Medicine
Synergistic interactions of the anti-casein kinase 2 CIGB-300 peptide and chemotherapeutic agents in lung and cervical preclinical cancer models
Yasser Perera, Neylen Del Toro, LARISA GOROVAYA, Jorge Fernández-de-Cossío, Hernán G. Fariña, Silvio E. Perea · 2014 · Molecular and Clinical Oncology
Quantitative phenotypic and pathway profiling guides rational drug combination strategies
John C. Dawson, Neil O. Carragher · 2014 · Frontiers in Pharmacology
Nanomedicine to Overcome Cancer Multidrug Resistance
Xi Yang, Yi An Cheng, Na Luo, Changyang Gong · 2014 · Current Drug Metabolism
Continuous Production of Janus and Composite Liquid Marbles with Tunable Coverage
Jasmine O. Castro, Bruna M. Neves, Amgad R. Rezk, Nicky Eshtiaghi, Leslie Y. Yeo · 2016 · ACS Applied Materials & Interfaces
Platinum covalent shell cross-linked micelles designed to deliver doxorubicin for synergistic combination cancer therapy
Caiying Zhu, Jing-jing Xiao, Ming Tang, Huajie Feng, Wulian Chen, Ming Du · 2017 · International Journal of Nanomedicine
Nanoparticles applied to cancer immunoregulation
Fernando López‐Campos, Daniele Candini, Eliseo Carrasco-Esteban, Miguel Ángel Berenguer Francés · 2018 · Reports of Practical Oncology & Radiotherapy
Synergistic cytotoxicity of erianin, a bisbenzyl in the dietetic Chinese herb Dendrobium against breast cancer cells
Hualing Xie, Simin Feng, Mohamed Ali Farag, Peilong Sun, Ping Shao · 2020 · Food and Chemical Toxicology
Network and systems biology: essential steps in virtualising drug discovery and development
Christoph Wierling, T. Keßler, Lesley Ann Ogilvie, Bodo M. H. Lange, Marie‐Laure Yaspo, Hans Lehrach · 2015 · Drug Discovery Today Technologies
Combinatorial strategies for oncolytic herpes simplex virus therapy of brain tumors
Ryuichi Kanai, Samuel D. Rabkin · 2013 · CNS Oncology
Emerging Developments in Targeting Proteotoxicity in Neurodegenerative Diseases
Luke McAlary, Steven Samuel Plotkin, Neil R. Cashman · 2019 · CNS Drugs
Dendrogenin A Synergizes with Cytarabine to Kill Acute Myeloid Leukemia Cells In Vitro and In Vivo
Nizar Serhan, Pierre‐Luc Mouchel, Philippe de Médina, Grégory Segala, Aurélie Mougel, Estelle Saland, Arnaud Rives, Antonin Lamazière, Gaëtan Després, Jean‐Emmanuel Sarry et al. · 2020 · Cancers
First-in-Class Dual Mechanism Ferroptosis-HDAC Inhibitor Hybrids
Endri Karaj, Shaimaa H. Sindi, Nishanth Kuganesan, Radhika Koranne, Joseph R. Knoff, Antonisamy William James, Yu Fu, Lauren N. Kotsull, Mary Kay H. Pflum, Zahoor Ahmad Shah et al. · 2022 · Journal of Medicinal Chemistry
DEML: Drug Synergy and Interaction Prediction Using Ensemble-Based Multi-Task Learning
Zhongming Wang, Jiahui Dong, Lianlian Wu, Chong Dai, Jing Wang, Yuqi Wen, Yixin Zhang, Xiaoxi Yang, Song He, Xiaochen Bo · 2023 · Molecules
Recent Advancements on Self‐Immolative System Based on Dynamic Covalent Bonds for Delivering Heterogeneous Payloads
Qingbing Wang, Maciej Serda, Quan Li, Tao Sun · 2023 · Advanced Healthcare Materials
Multi-omics landscapes of colorectal cancer subtypes discriminated by an individualized prognostic signature for 5-fluorouracil-based chemotherapy
M Tong, Weicheng Zheng, Hongdong Li, Xiangyü Li, Lu Ao, Yutong Shen, Q Liang, Jin Li, Guini Hong, Haidan Yan et al. · 2016 · Oncogenesis
An on-chip cell culturing and combinatorial drug screening system
Jiahui Sun, Wenjia Liu, Yulong Li, Azarmidokht Gholamipour‐Shirazi, Aynur Abdulla, Xianting Ding · 2017 · Microfluidics and Nanofluidics
How to find the right drug for each patient? Advances and challenges in pharmacogenomics
Angeliki Kalamara, Luis Tobalina, Julio Sáez-Rodríguez · 2018 · Current Opinion in Systems Biology
A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer
Jessica Ruzzolini, Anna Laurenzana, Elena Andreucci, Silvia Peppicelli, Francesca Bianchini, Fabrizio Carta, Claudiu Trandafir Supuran, María Novella Romanelli, Chiara Nediani, Lido Calorini · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
Bimetallic Nanomaterials: A Promising Nanoplatform for Multimodal Cancer Therapy
Guiming Niu, Fucheng Gao, Yandong Wang, Jie Zhang, Zhao Li, Yanyan Jiang · 2022 · Molecules
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast Cancer
James E. Korkola, Eric Andrew Collisson, Laura M. Heiser, Chris J. Oates, Nora Bayani, Sleiman M. Itani, Amanda M. Esch, Wallace Thompson, Obi L. Griffith, Nicholas J. Wang et al. · 2015 · PLoS ONE
Personalized Network-Based Treatments in Oncology
Xavier Robin, Pau Creixell, O Radetskaya, Cristina Costa Santini, James Longden, Rune Linding · 2013 · Clinical Pharmacology & Therapeutics
Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
Li Luo, Xun Jin, Bingwen Zou, Chuanhong Zhong, Peilan Zhang, Hao Cheng, Yan-Fang Guo, Maling Gou · 2016 · International Journal of Nanomedicine
Implementation of the NCI-60 Human Tumor Cell Line Panel to Screen 2260 Cancer Drug Combinations to Generate >3 Million Data Points Used to Populate a Large Matrix of Anti-Neoplastic Agent Combinations (ALMANAC) Database
David A. Close, Allen Xinwei Wang, Stanton J. Kochanek, Tongying Shun, Julie L. Eiseman, Paul A. Johnston · 2018 · SLAS DISCOVERY
Microfluidic cap-to-dispense (μCD): a universal microfluidic–robotic interface for automated pipette-free high-precision liquid handling
Jingjing Wang, Deng Ka, Chuqing Zhou, Zecong Fang, Conary C. Meyer, Kaustubh Deshpande, Zhihao Li, Xianqiang Mi, Qian Luo, Bruce D. Hammock et al. · 2019 · Lab on a Chip
Emerging Trends in Designing the Dendrimer-Based Drug Delivery for Antineoplastic Therapies
Mohammad Adnan Raza, Anjila Firdous, Umesh Dutta Gupta, Umesh Kumar Patil, Ambika Singh, M. Ajazuddin · 2025 · ACS Applied Bio Materials
Advances in Cancer Treatment Through Nanotheranostics and Emerging Therapies
Victor Akpe, Ian Edwin Cock · 2025 · Journal of Nanotheranostics
Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
Chen Qian, Li-Jun Yang, Hong Cui · 2020 · Frontiers in Pharmacology
Co-delivery systems: hope for clinical application?
Sepideh Nezhadi, Farid Abedin Dorkoosh · 2021 · Drug Delivery and Translational Research
Identifying clinically relevant drug resistance genes in drug-induced resistant cancer cell lines and post- chemotherapy tissues
Mengsha Tong, Weicheng Zheng, Xingrong Lu, Lu Ao, Xiangyü Li, Qingzhou Guan, Hao Cai, Mengyao Li, Haidan Yan, You Guo et al. · 2015 · Oncotarget
Selective Targeting of CTNNB1-, KRAS- or MYC-Driven Cell Growth by Combinations of Existing Drugs
Joost C.M. Uitdehaag, Jeroen A.D.M. de Roos, Antoon M. van Doornmalen, Martine B.W. Prinsen, J A P Spijkers-Hagelstein, Judith R.F. de Vetter, Jos de Man, Rogier C. Buijsman, Guido J.R. Zaman · 2015 · PLoS ONE
Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury
Bo Zhang, Cheng Chang Lu, Ming Bai, Xiaojuan He, Yong Tan, Yanqin Bian, Cheng Xiao, Ge Zhang, Aiping Lü, Shao Li · 2015 · Journal of Ethnopharmacology
Dual-drug loaded nanoneedles with targeting property for efficient cancer therapy
Xiangrui Yang, Shichao Wu, Wanyi Xie, Anran Cheng, Lichao Yang, Zhenqing Hou, Xin Jin · 2017 · Journal of Nanobiotechnology
Food-derived polyphenols inhibit the growth of ovarian cancer cells irrespective of their ability to induce antioxidant responses
Youngjoo Kwon · 2018 · Heliyon
Typing tumors using pathways selected by somatic evolution
Sheng Wang, Jianzhu Ma, Wei Zhang, John Paul Shen, Justin Kwang-Lay Huang, Jian Peng, Trey Ideker · 2018 · Nature Communications
Article Commentary: Predictive Modeling of Drug Treatment in the Area of Personalized Medicine
Lesley Ann Ogilvie, Christoph Wierling, Thomas Kessler, Hans Lehrach, Bodo M. H. Lange · 2015 · Cancer Informatics
Survival prediction landscape: an in-depth systematic literature review on activities, methods, tools, diseases, and databases
Ahtisham Fazeel Abbasi, Muhammad Nabeel Asim, Sheraz Ahmed, Sebastian J. Vollmer, Andreas Dengel · 2024 · Frontiers in Artificial Intelligence
Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review
Magdalena Kędzierska, Magdalena Bańkosz · 2024 · Journal of Clinical Medicine
Enzyme Prodrug Therapy Engineered into Biomaterials
Ana C. Mendes, Alexander N. Zelikin · 2014 · Advanced Functional Materials
Titration of signalling output: insights into clinical combinations of MEK and AKT inhibitors
A. Stewart, P. Thavasu, Johann Sebastian De Bono, Udai Banerji · 2015 · Annals of Oncology
Supramolecular nanofibers increase the efficacy of 10-hydroxycamptothecin by enhancing nuclear accumulation and depleting cellular ATP
Qingxiang Guo, Yifan Liu, Zhongyan Wang, Jiamin Zhang, Ganen Mu, Wei Wang, Jianfeng Liu · 2021 · Acta Biomaterialia
A colon-targeted podophyllotoxin nanoprodrug: synthesis, characterization, and supramolecular hydrogel formation for the drug combination
Wei Ha, Xiao-Bo Zhao, Weihua Zhao, Jiang‐Jiang Tang, Yan‐Ping Shi · 2021 · Journal of Materials Chemistry B
Dichloroacetate and PX-478 exhibit strong synergistic effects in a various number of cancer cell lines
Jonas Parczyk, Jérôme Ruhnau, Carsten Pelz, Max Schilling, Hao Wu, Nicole Nadine Piaskowski, Britta Johanna Eickholt, Hartmut Kühn, Kerstin Danker, Andreas Klein · 2021 · BMC Cancer
A CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics
Hyeong-Min Lee, William C. Wright, Min Pan, Jonathan A. Low, Duane G. Currier, Jie Fang, Shivendra Vikram Singh, Stephanie Nance, Ian Michael Delahunty, Yuna Kim et al. · 2023 · Nature Communications
Exome sequencing in tracking clonal evolution in multiple myeloma following therapy
Nicola J. Weston-Bell, J Gibson, Melford John, Sarah Ennis, Sabine Pfeifer, Timothée Cezard, Heinz Ludwig, Andrew R Collins, Niklas Zojer, Surinder Singh Sahota · 2012 · Leukemia
An Allosteric Inhibitor Scaffold Targeting the PIF-Pocket of Atypical Protein Kinase C Isoforms
José M. Arencibia, Wolfgang Fröhner, Magdalena Krupa, Daniel Pastor‐Flores, Piotr Merker, Thomas Oellerich, Sonja Neimanis, Christian Schmithals, Verena Köberle, Evelyn Süß et al. · 2017 · ACS Chemical Biology
Synergistic target combination prediction from curated signaling networks: Machine learning meets systems biology and pharmacology
Huey Eng Chua, Sourav Saha Bhowmick, Lisa Tucker‐Kellogg · 2017 · Methods
Dynamic Rearrangement of Cell States Detected by Systematic Screening of Sequential Anticancer Treatments
Simon Koplev, James Longden, Jesper Ferkinghoff‐Borg, Mathias Blicher Bjerregård, Thomas R. Cox, Janine Terra Erler, Jesper Torbøl Pedersen, Franziska Völlmy, Morten Otto Alexander Sommer, Rune Linding · 2017 · Cell Reports
Network based Approach to Drug Discovery: A Mini Review
Peng Li, Yingxue Fu, Yonghua Wang · 2015 · Mini-Reviews in Medicinal Chemistry
Therapeutic Applications of Rosmarinic Acid in Cancer-Chemotherapy-Associated Resistance and Toxicity
Cecilia Villegas, Nicole Cortez, Ayorinde Víctor Ogundele, Viviana Burgos, Paulo Celso Pardi, Jaime R. Cabrera‐Pardo, Cristian Paz · 2024 · Biomolecules
Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI
Mounia Beloueche‐Babari, Yann Jamin, Vaitha Arunan, Simon Walker‐Samuel, Mitchell Revill, Paul D. Smith, Jane L. Halliday, John C. Waterton, Hervé Barjat, Paul Workman et al. · 2013 · British Journal of Cancer
Maximizing the Value of Cancer Drug Screening in Multicellular Tumor Spheroid Cultures: A Case Study in Five Head and Neck Squamous Cell Carcinoma Cell Lines
Stanton J. Kochanek, David A. Close, Daniel P. Camarco, Paul A. Johnston · 2020 · SLAS DISCOVERY
Network-guided identification of cancer-selective combinatorial therapies in ovarian cancer
Liye He, Daria R. Bulanova, Jaana Oikkonen, Antti Häkkinen, Kaiyang Zhang, Shuyu Zheng, Wenyu Wang, Erdoğan Pekcan Erkan, Olli Carpén, Titta Joutsiniemi et al. · 2021 · Briefings in Bioinformatics
Targeted Disruption of E6/p53 Binding Exerts Broad Activity and Synergism with Paclitaxel and Topotecan against HPV-Transformed Cancer Cells
Marta Celegato, Lorenzo Messa, Chiara Bertagnin, Beatrice Mercorelli, Arianna Loregian · 2021 · Cancers
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms
Jérémy Ariey-Bonnet, Raphaël Bergès, Marie-Pierre Montero, Baptiste Mouysset, Patricia Piris, Kévin Müller, Guillaume Pinna, Timothy W. Failes, Greg M. Arndt, Philippe Morando et al. · 2023 · EBioMedicine
PANCDR: precise medicine prediction using an adversarial network for cancer drug response
Ju‐Yeon Kim, Sung‐Hye Park, Hyunju Lee · 2024 · Briefings in Bioinformatics
A self-assembled albumin based multiple drug delivery nanosystem to overcome multidrug resistance
Bin Chen, Cong Wu, Ren‐Xi Zhuo, Si‐Xue Cheng · 2014 · RSC Advances
A data-driven approach for evaluating multi-modal therapy in traumatic brain injury
Jenny Haefeli, Adam R. Ferguson, Deborah Bingham, Adrienne Orr, Seok Joon Won, Tina I. Lam, Jian Shi, Sarah Hawley, Jialing Liu, Raymond A. Swanson et al. · 2017 · Scientific Reports
The Generation of Three-Dimensional Head and Neck Cancer Models for Drug Discovery in 384-Well Ultra-Low Attachment Microplates
David A. Close, Daniel P. Camarco, Feng Shan, Stanton J. Kochanek, Paul A. Johnston · 2017 · Methods in molecular biology
A self-assembled, modular nucleic acid-based nanoscaffold for multivalent theranostic medicine
Veronica L. Andersen, Mathias Vinther, Rajesh Kumar, Annika Ries, Jesper Wengel, Jesper S. Nielsen, Jørgen Kjems · 2019 · Theranostics
The human proteome with direct physical access to DNA
Jakob Trendel, Simon Trendel, Shuyao Sha, Franziska Greulich, Sandra Goll, Susanne I. Wudy, Karin Kleigrewe, Stefan Kubicek, N. Henriette Uhlenhaut, Bernhard Küster · 2025 · Cell
Tumor Static Concentration Curves in Combination Therapy
Tim Cardilin, J.O. Almquist, Mats Jirstrand, Alexandre Sostelly, Christiane Amendt, Samer El Bawab, Johan Gabrielsson · 2016 · The AAPS Journal
Heterogeneous information network and its application to human health and disease
Pingjian Ding, Wenjue Ouyang, Jiawei Luo, Chee-Keong Kwoh · 2019 · Briefings in Bioinformatics
Dip‐Pen Nanolithography Enabled Functional Nanomaterials and Their Applications
Ze‐Qi Li, Ping Guo, Yi‐Ge Zhou · 2021 · Advanced Materials Technologies
Cell‐Derived Vesicles for Nanoparticles' Coating: Biomimetic Approaches for Enhanced Blood Circulation and Cancer Therapy
Carolina F. Rodrigues, Natanael F. Fernandes, Duarte de Melo‐Diogo, Ilídio Joaquim Correia, André Ferreira Moreira · 2022 · Advanced Healthcare Materials
Mechanistic Understanding of D-Glucaric Acid to Support Liver Detoxification Essential to Muscle Health Using a Computational Systems Biology Approach
V. A. Shiva Ayyadurai, Prabhakar Deonikar, Christine Fields · 2023 · Nutrients
Platelet-mimicking supramolecular nanomedicine with precisely integrated prodrugs for cascade amplification of synergistic chemotherapy
Yuan‐Fu Ding, Ziyi Wang, Cheryl H. T. Kwong, Yonghua Zhao, Greta S. P. Mok, Hua‐Zhong Yu, Ruibing Wang · 2023 · Journal of Controlled Release
Strategies and validation for siRNA-based therapeutics for the reversal of multi-drug resistance in cancer
Tahereh Fatemian, Iekhsan Othman, Ezharul Hoque Chowdhury · 2013 · Drug Discovery Today
Preclinical optimization of a broad-spectrum anti-bladder cancer tri-drug regimen via the Feedback System Control (FSC) platform
Qi Liu, Cheng Long Zhang, Xianting Ding, Hui Deng, Daming Zhang, Wei Cui, Hongwei Xu, Yingwei Wang, Wanhai Xu, Lei Lv et al. · 2015 · Scientific Reports
Vitamin E-based prodrug self-delivery for nanoformulated irinotecan with synergistic antitumor therapeutics
Longbing Ling, Muhammad Ismail, Zhi‐Hao Shang, Yihui Hu, Benhong Li · 2020 · International Journal of Pharmaceutics
Progressive Hemorrhage and Myotoxicity Induced by Echis carinatus Venom in Murine Model: Neutralization by Inhibitor Cocktail of N,N,N',N'-Tetrakis (2-Pyridylmethyl) Ethane-1,2-Diamine and Silymarin
Ankanahalli N. Nanjaraj Urs, C. V. Ramakrishnan, Vikram Joshi, Kanve Nagaraj Suvilesh, T. Veerabasappa Gowda, Devadasan Velmurugan, Bannikuppe Sannanaik Vishwanath · 2015 · PLoS ONE
Poly (Glycerol Adipate): From a Functionalized Nanocarrier to a Polymeric-Prodrug Matrix to Create Amorphous Solid Dispersions
Dipak Gordhan, Sadie M.E. Swainson, Amanda K. Pearce, Ioanna Danai Styliari, Tatiana Lovato, J. Burley, Martin C. Garnett, Vincenzo Taresco · 2019 · Journal of Pharmaceutical Sciences